Expert Interview
Examining the potential of Eton Pharma’s EM-100 in treating Allergic conjunctivitis
Ticker(s): ETON, BHCAn ophthalmologist with knowledge about EM-100 and experience with competing drugs in Allergic conjunctivitis.
Please tell us about your experience as a clinician.
Added By: slingshot_insightsHow big is the need for over-the-counter preservative-free eye drop for the treatment of ocular itching associated with allergic conjunctivitis?
Added By: slingshot_insightsIn the Phase 3 trial comparing EM-100 to Zaditor, EM-100 demonstrated non-inferiority in reducing ocular itching (ketotifen fumarate ophthalmic answer zero.035%) . What can you tell us about Zaditor’s efficacy in your patients? Would you choose EM-100 instead?
Added By: slingshot_insightsWhat % of the patient population would benefit from EM-100 if approved?
Added By: slingshot_insightsAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
